Neuraxis reports first quarter 2024 financial results

Carmel, ind., may 22, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter 2024 for the period ended march 31, 2024.
NRXS Ratings Summary
NRXS Quant Ranking